
    
      Cardiovascular disease accounts for nearly 50% of the mortality and is the most frequent
      cause of hospitalization in ESRD patients. Hyperphosphatemia is increasingly recognized to be
      an important predictor of mortality and cardiovascular death in ESRD patients and is largely
      attributed to the increased prevalence of vascular calcification.
    
  